| Patient | Srinivasa Ramanujan |
|---|---|
| Date of birth | 1887-12-22 |
| Identifiers | MRN HR-ET020-SYN-TD; SSN (made up) 000-20-1937 |
| Document date | 1917-01-14 |
| Author | Edmund Ashworth, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Results of the abdominal ultrasound, serology and tuberculosis tests, with an infectious diseases consultation, and start of treatment. [S]
Mr. Ramanujan returns two days after his first visit. He had the abdominal ultrasound yesterday morning and gave the second and third induced sputum samples yesterday and this morning, staying in his room in between as asked. He still has evening fevers, last night to 38.4 °C, with sweats, and the dull ache under his right ribs, worse when he breathes in deeply. He is eating little and taking acetaminophen. He has had no diarrhea for several years. He has read about tuberculosis and is frightened of it. He met Dr. Raghunathan of infectious diseases here today. [S]
| Element | Detail |
|---|---|
| Fever | Evening fevers to 38.4 °C with sweats |
| Pain | Dull right upper quadrant ache, worse on deep breathing |
| Tests since intake | Ultrasound yesterday; sputum samples two and three |
| Concern | Afraid he has tuberculosis |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Evening fevers, sweats, tiredness, poor appetite |
| Respiratory | Positive | Pain at the right base on deep breathing; slight dry cough; no blood in the sputum |
| Gastrointestinal | Positive | Right upper quadrant ache; no diarrhea, blood in the stool or jaundice |
| Neurological | Negative | No numbness or tingling |
| Psychiatric | Positive | Worried and low; no thoughts of self-harm |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Metronidazole 250 mg oral tablet, three tablets (750 mg) three times a day with food for 10 days | Three tablets every 8 hours with food for 10 days | Oral route | 1917-01-14 to 1917-01-23 | completed | S |
| Vitamin B12 (cyanocobalamin) 1,000 microgram oral tablet, one tablet daily | One tablet daily | Oral route | 1917-01-14 | active | S |
| Cholecalciferol 50,000 unit (1.25 mg) oral tablet, one tablet once a week for 8 weeks | One tablet once a week for 8 weeks | Oral route | 1917-01-14 to 1917-03-04 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1917-01-14 | Body height | 165 | cm | S |
| 1917-01-14 | Body weight | 51.8 | kg | S |
| 1917-01-14 | Body mass index (BMI) [Ratio] | 19 | kg/m2 | S |
| 1917-01-14 | Systolic blood pressure | 110 | mm[Hg] | S |
| 1917-01-14 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 1917-01-14 | Heart rate | 100 | /min | S |
| 1917-01-14 | Respiratory rate | 18 | /min | S |
| 1917-01-14 | Body temperature | 38.2 | Cel | S |
| 1917-01-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
Vital signs recorded on 1917-01-14; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Thin and tired; temperature 38.2 °C, pulse 100; weight 51.8 kg |
| Respiratory | Reduced breath sounds and dullness at the right base; otherwise clear |
| Abdomen | Liver edge 3 cm below the right costal margin and tender; tenderness over the right lower intercostal spaces; no jaundice |
| Neurological | Vibration and position sense normal in the feet; reflexes normal; gait normal |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Evening fevers to 38.6 °C with night sweats for about four weeks | resolved | confirmed | R50.9 | S — Synthetic presenting symptom, superseded by the diagnosis at the second visit. |
| Weight loss of 5 kg over two months (57 to 52 kg), with poor appetite | resolved | confirmed | R63.4 | S — Synthetic presenting symptom, superseded by the diagnosis at the second visit. |
| Dull right upper quadrant pain for three weeks, worse on deep breathing and lying on the right side, with a tender liver edge | resolved | confirmed | R10.11 | S — Synthetic presenting symptom, superseded by the diagnosis at the second visit. |
| Amebic liver abscess: a single 6.2 x 5.4 cm abscess in the right lobe (segment VII) on ultrasound, Entamoeba histolytica antibody positive, blood cultures negative, years after two episodes of dysentery in India; treated with metronidazole and then paromomycin; synthetic modern diagnosis linked to the hepatic amoebiasis later proposed for his illness | active | confirmed | A06.4 | S — Synthetic modern diagnosis; it does not settle the historical diagnostic conflict (CLM-0010, CLM-0011). |
| Vitamin B12 deficiency from a strict vegetarian diet (B12 168 pg/mL), with anemia (hemoglobin 11.2 g/dL, MCV 99 fL) to which inflammation also contributes | active | confirmed | D51.3 | S — Synthetic finding anchored to his documented diet and the vitamin deficiency later proposed. |
| Vitamin D deficiency (25-hydroxyvitamin D 9 ng/mL) | active | confirmed | E55.9 | S — Synthetic finding anchored to his documented diet and the vitamin deficiency later proposed. |
| Positive interferon-gamma release assay, with chest radiograph and sputum smears and NAAT negative for tuberculosis; cultures pending | active | confirmed | R76.12 | S — Synthetic finding, superseded by the diagnosis of latent infection when cultures were negative. |
| Adjustment disorder with depressed mood (PHQ-9 12, no thoughts of self-harm) during a serious illness, far from his wife and family | active | confirmed | F43.21 | S — Synthetic modern diagnosis anchored to his documented loneliness; not a claim about his real mental health. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Temperature, symptoms and abdominal examination (liver tenderness, right lower rib tenderness) | Every visit | Completed today | 38.2 °C; tender liver edge 3 cm below the costal margin; right intercostal tenderness |
| Examination | Weight and BMI | Every visit | Completed today | 51.8 kg, BMI 19.0 |
| Imaging | Liver imaging | At diagnosis; repeat only for no response or a complication | Completed today | Single 6.2 x 5.4 cm right-lobe abscess; no drainage needed |
| Laboratory | Entamoeba histolytica serology, stool antigen and microscopy, blood cultures | At diagnosis | Completed today | Serology positive; stool antigen and microscopy negative; blood cultures no growth at 48 hours |
| Laboratory | Sputum acid-fast smears, NAAT and mycobacterial cultures | Three samples at baseline; cultures final at 6 to 8 weeks | Completed today | Three smears and the first NAAT negative; cultures pending |
| Laboratory | Interferon-gamma release assay and chest radiograph | At baseline | Completed today | IGRA positive; radiograph without lung disease |
| Laboratory | Blood count and C-reactive protein | At diagnosis, at the end of the tissue course, then until normal | Up to date | At intake: white cells 13.6, hemoglobin 11.2, platelets 412; CRP 92 mg/L |
| Laboratory | Liver tests (alkaline phosphatase, ALT, AST, bilirubin, albumin) | At diagnosis, at the end of therapy, and before and during rifampin | Up to date | At intake: alkaline phosphatase 214, ALT 46 U/L, albumin 3.2 g/dL |
| Medication safety | Amebicide safety and completion (nausea, metallic taste, numbness on metronidazole; diarrhea on paromomycin; no overlap) | At the start and every visit during treatment | Completed today | Side effects explained; metronidazole started today, paromomycin to follow and not overlap |
| Examination | Response to vitamin B12 replacement | Reticulocyte count at 1 week; blood count at about 8 weeks; neurologic examination at diagnosis | Completed today | Neurologic examination normal; B12 started today; reticulocyte count due in one week |
| Laboratory | 25-hydroxyvitamin D | At diagnosis; after repletion | Up to date | 9 ng/mL at intake; repletion started today |
| Self-management | Diet and weight plan within his vegetarian rules | Every visit | Completed today | Dietitian visit booked for next week |
| Survey | PHQ-9 and GAD-7 | At least monthly while symptoms are active | Up to date | PHQ-9 12 and GAD-7 9 two days ago |
| Survey | Suicide-risk review, safety plan and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or self-harm; safety plan and the 988 Lifeline in his phone |
| Self-management | Support far from home (counseling, contact with family and community, department and fellowship) | Every visit | Completed today | Counseling booked; letter for his fellowship given; international student office contacted with his agreement |
| Referral | Infectious diseases review | At diagnosis; then at six weeks for the cultures and latent infection | Completed today | Seen by Dr. Raghunathan today |
Goal progress:
Guideline basis: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis (2016); Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children (2017); DPDx: Amebiasis (laboratory diagnosis, including antibody detection in extraintestinal disease) (2026); A Review of the Global Burden, New Diagnostics, and Current Therapeutics for Amebiasis (2018); Position of the Academy of Nutrition and Dietetics: Vegetarian Diets (2016); CMID: Clinical Monitoring Intelligence Database, anemia and depression monographs (2026); Depression and Suicide Risk in Adults: Screening (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024)
Follow-up: Nurse phone call on the third day of metronidazole. Review in 12 days, at the end of metronidazole, with a blood count, CRP and liver tests. Call at once for severe abdominal pain, worse breathlessness, fainting or yellowing of the eyes. Next scheduled visit 1917-01-26: day 12: end of metronidazole and start of paromomycin, blood count, CRP and liver tests, mood and safety review. [S]